Durata Therapeutics

Nabriva

This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.

Paratek

This company develops and supplies antibiotics and specialty medicines for healthcare providers treating serious infectious diseases and osteoporosis.

Calixa Therapeutics

This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.

Paratek Pharmaceuticals

This company develops and commercialises antibiotics and nasal sprays for patients with infectious diseases, pneumonia, skin infections and chronic rhinosinusitis.

Melinta Therapeutics

This biopharmaceutical company develops and commercialises antibiotics and antifungals to treat drug-resistant infections in hospital and clinic settings.

Iterum Therapeutics

This pharmaceutical company develops and commercialises oral and intravenous antibiotics for patients with multi-drug resistant infections, including urinary tract infections.

Cerexa

This biopharmaceutical company develops hospital-based anti-infective therapies for patients with serious and life-threatening infections.

Amprologix

This biotechnology company develops novel antibiotics to treat antimicrobial-resistant bacterial infections for patients with conditions including MRSA and related skin and wound infections.